CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 82 enrolled
Drug / intervention
Siempre Seguirébehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03432819
NCT03432819N/ACompleted
CompareCT.gov

A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM

RAND·interventional·Posted Feb 14, 2018·Updated Mar 29, 2023

In Brief

A clinical study evaluating Siempre Seguiré for HIV. Completed, enrolled 82 participants across 1 site.

Detailed Summary

R34-funded study to pilot test an intervention to improve coping with discrimination and adherence among Latino men who have sex with men (MSM) living with HIV. The proposed research aims to modify and refine Siempre Seguiré, a culturally congruent cognitive behavior therapy group intervention for HIV-positive Latino men who have sex with men (LMSM), to include strategies for ART adherence and retention in HIV care; and to conduct a small randomized pilot of Siempre Seguiré to examine feasibility and acceptability, as well as to explore preliminary effects on coping responses to discrimination and antiretroviral treatment adherence among LMSM living with HIV.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV
CountriesUnited States
CollaboratorsBienestar Human Services, Inc.

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 14, 2018
Enrollment StartMar 27, 2018
Primary CompletionSep 12, 2019
Study CompletionSep 16, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.4 years ago

Interventions

Siempre Seguirébehavioral

A culturally congruent CBT group intervention for HIV-positive LMSM, to include strategies for ART adherence and retention in HIV care.